| 1 | Brugada syndrome | Enrichment | ABCC9, AKAP9, CACNA1C, CACNB2, KCND3, KCNE3, KCNE5, KCNH2, RANGRF, SCN10A, SCN1B, SCN2B, SCN3B, SCN5A | 16.00 |
| 2 | Sudden infant death syndrome | Enrichment | CALM2, CAV3, KCNQ1, MYBPC3, PLN, SCN1A, SCN5A, TNNI3, TTN | 16.00 |
| 3 | Familial hypertrophic cardiomyopathy | Enrichment | ACTC1, ACTN2, CAV3, DES, DMD, KCNH2, MYBPC3, MYL2, MYL3, TCAP, TNNI3, TNNT2, TPM1 | 16.00 |
| 4 | Long qt syndrome | Enrichment | AKAP9, CACNA1C, CALM1, CALM2, CASQ2, CAV3, KCNE1, KCNH2, KCNQ1, MYBPC3, MYH6, RYR2, SCN5A | 16.00 |
| 5 | Distal arthrogryposis | Enrichment | ACTA1, ACTC1, ATP2B3, MYBPC1, MYH3, MYL11, RYR1, SCN4A, SCN5A, SCN8A, TNNI2, TPM2 | 12.17 |
| 6 | Hypertrophic cardiomyopathy | Enrichment | ACTC1, ACTN2, MYBPC3, MYL2, MYL3, PLN, TCAP, TNNC1, TNNI3, TNNT2, TPM1, TTN | 11.84 |
| 7 | Dilated cardiomyopathy | Enrichment | ACTA1, ACTC1, ACTN2, DES, DMD, KCNE1, MYBPC3, MYH6, MYL2, NKX2-5, PLN, SCN5A, TBX5, TCAP, TNNI3, TNNT2, TPM1, TTN, VCL | 11.13 |
| 8 | Long qt syndrome 1 | Enrichment | AKAP9, CACNA1C, CALM1, CALM2, CALM3, CAV3, ITPR3, KCNE1, KCNE2, KCNH2, KCNQ1, SCN10A, SCN4B, SCN5A, TBX5, TRDN | 10.88 |
| 9 | Familial atrial fibrillation | Enrichment | ABCC9, GATA4, KCNA5, KCNE1, KCNE2, KCNJ2, KCNQ1, MYL4, NKX2-5, NPPA, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, TTN | 10.74 |
| 10 | Familial isolated dilated cardiomyopathy | Enrichment | ABCC9, ACTC1, ACTN2, DES, DMD, MYBPC3, MYH6, PLN, SCN5A, TCAP, TNNC1, TNNI3, TNNT2, TPM1, TTN, VCL | 10.72 |
| 11 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | CALM1, CALM2, CALM3, CASQ2, RYR2, TRDN | 10.46 |
| 12 | Left ventricular noncompaction | Enrichment | ACTC1, ACTN2, MYBPC3, NKX2-5, RYR2, SCN5A, TNNI3, TNNT2, TPM1, TTN | 10.20 |
| 13 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | CALM1, CASQ2, RYR2, TRDN | 8.41 |
| 14 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | CALM1, CASQ2, RYR2, TRDN | 7.74 |
| 15 | Arthrogryposis, distal, type 1a | Enrichment | MYBPC1, MYH3, TNNI2, TNNT3, TPM2 | 7.39 |
| 16 | Congenital long qt syndrome | Enrichment | KCNE1, KCNH2, KCNQ1 | 7.35 |
| 17 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | CACNA1C, CAV3, MYBPC3, MYH6, TNNI3, TNNT2, TPM1 | 7.34 |
| 18 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | Enrichment | ACTG2, LMOD1, MYH11, MYLK | 7.30 |
| 19 | Cardiac conduction defect | Enrichment | CACNA1C, PLN, RYR2, SCN1B, SCN5A | 7.22 |
| 20 | Wolff-parkinson-white syndrome | Enrichment | ABCC9, CASQ2, KCNQ1, SCN5A, TNNT2, TTN | 7.11 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | ACTN2, DES, MYBPC3, RYR1, RYR2, SCN5A | 7.11 |
| 22 | Cardiomyopathy, dilated, 1e | Enrichment | DES, MYL2, SCN5A, TNNC1, TPM1, TTN | 6.92 |
| 23 | Generalized epilepsy with febrile seizures plus | Enrichment | FGF13, SCN1A, SCN1B, SCN2A, SCN9A | 6.82 |
| 24 | Visceral myopathy 1 | Enrichment | ACTG2, LMOD1, MYH11, MYLK | 6.60 |
| 25 | Arthrogryposis, distal, type 2b1 | Enrichment | MYH3, TNNI2, TNNT3, TPM2 | 6.60 |
| 26 | Heart disease | Enrichment | GATA4, NKX2-5, TBX5 | 6.50 |
| 27 | Jervell-lange nielsen syndrome | Enrichment | KCNE1, KCNQ1 | 6.41 |
| 28 | Patent foramen ovale | Enrichment | GATA4, NKX2-5, TBX5 | 6.15 |
| 29 | Hereditary sodium channelopathy-related small fibers neuropathy | Enrichment | SCN10A, SCN11A, SCN9A | 6.05 |
| 30 | Undetermined early-onset epileptic encephalopathy | Enrichment | ATP1A2, ATP1A3, FGF12, SCN1A, SCN1B, SCN3A, SCN8A | 5.96 |
| 31 | Brugada syndrome 1 | Enrichment | KCNH2, MYBPC3, SCN10A, SCN5A | 5.77 |
| 32 | Childhood-onset nemaline myopathy | Enrichment | ACTA1, NEB, TPM2, TPM3 | 5.77 |
| 33 | Dravet syndrome | Enrichment | SCN1A, SCN1B, SCN2A, SCN9A | 5.76 |
| 34 | Congenital myopathy 4a, autosomal dominant | Enrichment | ACTA1, MYL2, RYR1, TPM2, TPM3 | 5.70 |
| 35 | Epilepsy | Enrichment | ATP1A2, ATP1A3, SCN1A, SCN2A, SCN3A, SCN8A | 5.65 |
| 36 | Jervell and lange-nielsen syndrome 1 | Enrichment | KCNE1, KCNQ1 | 5.63 |
| 37 | Long qt syndrome 2 | Enrichment | KCNH2, KCNQ1 | 5.63 |
| 38 | Myopathy, tubular aggregate, 1 | Enrichment | CASQ1, CAV3, ORAI1, STIM1 | 5.47 |
| 39 | Erythermalgia, primary | Enrichment | SCN10A, SCN11A, SCN9A | 5.45 |
| 40 | Ventricular fibrillation, paroxysmal familial, 1 | Enrichment | CACNA1C, RYR2, SCN5A | 5.45 |
| 41 | Atrial fibrillation | Enrichment | CORIN, KCNQ1, SCN5A | 5.45 |
| 42 | Hereditary progressive cardiac conduction defect | Enrichment | NKX2-5, SCN1B, SCN5A | 5.45 |
| 43 | Congenital short qt syndrome | Enrichment | KCNH2, KCNQ1 | 5.41 |
| 44 | Paroxysmal extreme pain disorder | Enrichment | SCN10A, SCN11A, SCN9A | 5.05 |
| 45 | Heart conduction disease | Enrichment | CACNA1C, RYR2, SCN5A | 5.05 |
| 46 | Nemaline myopathy | Enrichment | ACTA1, NEB, TPM2, TPM3 | 5.00 |
| 47 | Intermediate nemaline myopathy | Enrichment | ACTA1, NEB, TPM3 | 4.87 |
| 48 | Stormorken syndrome | Enrichment | ORAI1, STIM1 | 4.78 |
| 49 | Ventricular tachycardia, catecholaminergic polymorphic, 2 | Enrichment | CASQ2, RYR2 | 4.78 |
| 50 | Exercise-induced malignant hyperthermia | Enrichment | ASPH, RYR1 | 4.78 |
| 51 | Fetal akinesia deformation sequence 1 | Enrichment | ACTA1, ATP2B3, RYR1, SCN4A, SCN5A, SCN8A | 4.76 |
| 52 | Developmental and epileptic encephalopathy | Enrichment | CACNA2D2, SCN1A, SCN2A, SCN3A, SCN8A | 4.62 |
| 53 | Myopathy | Enrichment | ACTA1, DMD, RYR1, SCN4A, TPM3, TTN | 4.56 |
| 54 | Neuropathy, hereditary sensory and autonomic, type v | Enrichment | SCN10A, SCN11A, SCN9A | 4.51 |
| 55 | Alternating hemiplegia of childhood | Enrichment | ATP1A2, ATP1A3, SCN2A | 4.31 |
| 56 | Atrial heart septal defect | Enrichment | NKX2-5, TBX5 | 4.27 |
| 57 | Interatrial communication | Enrichment | NKX2-5, TBX5 | 4.27 |
| 58 | Typical nemaline myopathy | Enrichment | ACTA1, NEB, TPM2 | 4.18 |
| 59 | Migraine with aura 13 | Enrichment | KCNK18 | 4.13 |
| 60 | Isolated atrial standstill | Enrichment | NPPA, SCN5A | 4.03 |
| 61 | Malignant hyperthermia | Enrichment | ASPH, RYR1 | 4.00 |
| 62 | Familial isolated restrictive cardiomyopathy | Enrichment | MYL2, TNNI3, TNNT2 | 3.94 |
| 63 | Neuromuscular disease | Enrichment | ACTA1, DES, RYR1, TTN | 3.88 |
| 64 | Pulmonary hypertension, primary, 4 | Enrichment | KCNK3 | 3.83 |
| 65 | Heart, malformation of | Enrichment | GATA4, TBX5 | 3.82 |
| 66 | Congenital myopathy | Enrichment | ACTA1, RYR1, SCN4A, TTN | 3.78 |
| 67 | Myocarditis | Enrichment | TNNI3, TNNT2, TTN | 3.74 |
| 68 | Cardiomyopathy, dilated, 1i | Enrichment | DES, MYBPC3 | 3.64 |
| 69 | Cardiomyopathy, familial hypertrophic, 25 | Enrichment | TCAP, TNNI3 | 3.64 |
| 70 | Centronuclear myopathy | Enrichment | ACTA1, RYR1, TPM3, TTN | 3.61 |
| 71 | Cardiomyopathy, familial hypertrophic, 4 | Enrichment | MYBPC3, TNNI3, TNNT2 | 3.57 |
| 72 | Dystonia 12 | Enrichment | ATP1A3, SCN2A | 3.55 |
| 73 | Generalized epilepsy with febrile seizures plus, type 1 | Enrichment | SCN1A, SCN1B | 3.55 |
| 74 | Birk-barel syndrome | Enrichment | KCNK9 | 3.53 |
| 75 | Short qt syndrome 3 | Enrichment | KCNJ2 | 3.53 |
| 76 | Atrial fibrillation, familial, 9 | Enrichment | KCNJ2 | 3.53 |
| 77 | Tetralogy of fallot | Enrichment | GATA4, NKX2-5 | 3.50 |
| 78 | Muscular dystrophy | Enrichment | DMD, DYSF, NEB, TTN | 3.37 |
| 79 | Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome | Enrichment | KCNK4 | 3.35 |
| 80 | Spinocerebellar ataxia 19 | Enrichment | KCND3 | 3.29 |
| 81 | Brugada syndrome 9 | Enrichment | KCND3 | 3.29 |
| 82 | Spinocerebellar ataxia type 19/22 | Enrichment | KCND3 | 3.29 |
| 83 | Familial or sporadic hemiplegic migraine | Enrichment | ATP1A2, SCN1A | 3.25 |
| 84 | Paroxysmal familial ventricular fibrillation | Enrichment | RYR2, SCN5A | 3.25 |
| 85 | Andersen cardiodysrhythmic periodic paralysis | Enrichment | KCNJ2 | 3.23 |
| 86 | Hydrops fetalis | Enrichment | RYR1, RYR3 | 3.23 |
| 87 | Benign epilepsy with centrotemporal spikes | Enrichment | SCN1A, SCN1B, SCN2A, SCN9A | 3.18 |
| 88 | Gingival overgrowth | Enrichment | KCNK4 | 3.18 |
| 89 | Atrial fibrillation, familial, 7 | Enrichment | KCNA5 | 3.18 |
| 90 | Jervell and lange-nielsen syndrome 2 | Enrichment | KCNE1 | 3.18 |
| 91 | Short qt syndrome 1 | Enrichment | KCNH2 | 3.18 |
| 92 | Long qt syndrome 5 | Enrichment | KCNE1 | 3.18 |
| 93 | Long qt syndrome 11 | Enrichment | AKAP9 | 3.18 |
| 94 | Brugada syndrome 6 | Enrichment | KCNE3 | 3.18 |
| 95 | Autism | Enrichment | ATP2B1, CAMK2G, SCN1A, SCN2A, SCN8A | 3.17 |
| 96 | Myopathy, myofibrillar, 1 | Enrichment | DES, TTN | 3.17 |
| 97 | Intrinsic cardiomyopathy | Enrichment | ACTN2, PLN | 3.17 |
| 98 | Cap myopathy | Enrichment | TPM2, TPM3 | 3.17 |
| 99 | Restrictive cardiomyopathy | Enrichment | TNNI3, TNNT2, TTN | 3.17 |
| 100 | Centralopathic epilepsy | Enrichment | SCN1A, SCN1B, SCN2A, SCN9A | 3.10 |
| 101 | Cardiac arrest | Enrichment | PLN, SCN5A | 3.04 |
| 102 | Self-limited infantile epilepsy | Enrichment | SCN2A, SCN8A | 3.04 |
| 103 | Hypertension, diastolic | Enrichment | KCNIP1 | 2.99 |
| 104 | Atrial septal defect 7 with or without atrioventricular conduction defects | Enrichment | NKX2-5 | 2.99 |
| 105 | Hypothyroidism, congenital, nongoitrous, 5 | Enrichment | NKX2-5 | 2.99 |
| 106 | Holt-oram syndrome | Enrichment | TBX5 | 2.99 |
| 107 | Spinocerebellar ataxia 43 | Enrichment | MME | 2.99 |
| 108 | Atrioventricular septal defect 4 | Enrichment | GATA4 | 2.99 |
| 109 | Drug metabolism, altered, ces1-related | Enrichment | CES1 | 2.99 |
| 110 | Atrial septal defect 2 | Enrichment | GATA4 | 2.99 |
| 111 | Ventricular septal defect 3 | Enrichment | NKX2-5 | 2.99 |
| 112 | Preeclampsia/eclampsia 5 | Enrichment | CORIN | 2.99 |
| 113 | Testicular anomalies with or without congenital heart disease | Enrichment | GATA4 | 2.99 |
| 114 | Hypoplastic left heart syndrome 2 | Enrichment | NKX2-5 | 2.99 |
| 115 | 8p23.1 microdeletion syndrome | Enrichment | GATA4 | 2.99 |
| 116 | Congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization | Enrichment | MME | 2.99 |
| 117 | Cardiomyopathy, familial hypertrophic, 30, atrial | Enrichment | CORIN | 2.99 |
| 118 | Charcot-marie-tooth disease type 2t | Enrichment | MME | 2.99 |
| 119 | Mme-related autosomal dominant charcot marie tooth disease type 2 | Enrichment | MME | 2.99 |
| 120 | Aortic arch interruption | Enrichment | NKX2-5 | 2.99 |
| 121 | Atrial heart septal defect 7 | Enrichment | NKX2-5 | 2.99 |
| 122 | Partial atrioventricular septal defect with ventricular hypoplasia | Enrichment | GATA4 | 2.99 |
| 123 | Epicanthus | Enrichment | ABCC9, ATP1A3 | 2.97 |
| 124 | Aortic aneurysm, familial thoracic 1 | Enrichment | GATA4, MYH11, MYLK | 2.96 |
| 125 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | PLN, RYR2, TTN | 2.96 |
| 126 | Brugada syndrome 4 | Enrichment | CACNB2 | 2.96 |
| 127 | Brugada syndrome 3 | Enrichment | CACNA1C | 2.96 |
| 128 | Atypical timothy syndrome | Enrichment | CACNA1C | 2.96 |
| 129 | Timothy syndrome type 2 | Enrichment | CACNA1C | 2.96 |
| 130 | Timothy syndrome type 1 | Enrichment | CACNA1C | 2.96 |
| 131 | Cacna1c-related disorders | Enrichment | CACNA1C | 2.96 |
| 132 | Rare genetic deafness | Enrichment | KCNE1, KCNQ1 | 2.93 |
| 133 | Spastic ataxia | Enrichment | ATP1A2, ATP2B3, CACNA1G, ITPR1, SCN2A | 2.92 |
| 134 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | ATP2B1, RYR1 | 2.90 |
| 135 | Clubfoot | Enrichment | ATP2B1, RYR1 | 2.90 |
| 136 | Long qt syndrome 6 | Enrichment | KCNE2 | 2.88 |
| 137 | Atrial fibrillation, familial, 4 | Enrichment | KCNE2 | 2.88 |
| 138 | Cardiovascular system disease | Enrichment | KCNQ1 | 2.88 |
| 139 | Nemaline myopathy 2 | Enrichment | ACTA1, NEB | 2.87 |
| 140 | Myopathy, centronuclear, 2 | Enrichment | RYR1, TTN | 2.87 |
| 141 | Mitral valve insufficiency | Enrichment | MYH11, TBX5 | 2.87 |
| 142 | Familial sick sinus syndrome | Enrichment | MYH6, SCN5A | 2.87 |
| 143 | Hypokalemic periodic paralysis, type 1 | Enrichment | KCNE3, SCN4A | 2.86 |
| 144 | Heritable pulmonary arterial hypertension | Enrichment | KCNK3 | 2.79 |
| 145 | Creatine phosphokinase, elevated serum | Enrichment | CAV3, DMD, TCAP | 2.78 |
| 146 | Isolated elevated serum creatine phosphokinase levels | Enrichment | CAV3, DMD, TCAP | 2.78 |
| 147 | Focal epilepsy | Enrichment | SCN2A, SCN8A | 2.72 |
| 148 | Pulmonary hypertension, primary, 1 | Enrichment | KCNK3 | 2.72 |
| 149 | Platelet disorder, familial, with associated myeloid malignancy | Enrichment | KCNE2 | 2.70 |
| 150 | Atrial fibrillation, familial, 3 | Enrichment | KCNQ1 | 2.70 |
| 151 | Short qt syndrome 2 | Enrichment | KCNQ1 | 2.70 |
| 152 | Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation | Enrichment | KCNH2 | 2.70 |
| 153 | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with runx1 | Enrichment | KCNE2 | 2.70 |
| 154 | Thumb deformity | Enrichment | TBX5 | 2.69 |
| 155 | Atrial fibrillation, familial, 6 | Enrichment | NPPA | 2.69 |
| 156 | Epiphyseal chondrodysplasia, miura type | Enrichment | NPR2 | 2.69 |
| 157 | Acromesomelic dysplasia 1 | Enrichment | NPR2 | 2.69 |
| 158 | 46,xy sex reversal 3 | Enrichment | GATA4 | 2.69 |
| 159 | Aortic valve disease 2 | Enrichment | TBX5 | 2.69 |
| 160 | Charcot-marie-tooth disease, axonal, type 2t | Enrichment | MME | 2.69 |
| 161 | Familial isolated congenital asplenia | Enrichment | NKX2-5 | 2.69 |
| 162 | Deletion 5q35 | Enrichment | NKX2-5 | 2.69 |
| 163 | Congenital myopathy 1b, autosomal recessive | Enrichment | RYR1, TTN | 2.66 |
| 164 | Congenital myopathy 3 with rigid spine | Enrichment | ACTA1, TTN | 2.66 |
| 165 | Severe congenital nemaline myopathy | Enrichment | ACTA1, NEB | 2.66 |
| 166 | Timothy syndrome | Enrichment | CACNA1C | 2.66 |
| 167 | Long qt syndrome 8 | Enrichment | CACNA1C | 2.66 |
| 168 | Beckwith-wiedemann syndrome | Enrichment | DMD, KCNQ1, RYR1 | 2.63 |
| 169 | Amme complex | Enrichment | KCNE5 | 2.58 |
| 170 | Cardiomyopathy, familial hypertrophic, 26 | Enrichment | KCNH2 | 2.58 |
| 171 | Pregnancy loss, recurrent 1 | Enrichment | KCNQ1 | 2.58 |
| 172 | Early myoclonic encephalopathy | Enrichment | KCND2 | 2.51 |
| 173 | Atrial standstill 2 | Enrichment | NPPA | 2.51 |
| 174 | Epilepsy, familial focal, with variable foci 2 | Enrichment | NPR2 | 2.51 |
| 175 | Developmental and epileptic encephalopathy 14 | Enrichment | SCN1A, SCN2A | 2.49 |
| 176 | Atrial septal defect 1 | Enrichment | TBX5, TPM1 | 2.48 |
| 177 | Moyamoya disease 1 | Enrichment | ACTA2, GUCY1A1 | 2.48 |
| 178 | Inflammatory myofibroblastic tumor | Enrichment | TPM3, TPM4 | 2.48 |
| 179 | Intestinal pseudo-obstruction | Enrichment | ACTG2, MYH11 | 2.48 |
| 180 | Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures | Enrichment | CACNA1C | 2.48 |
| 181 | Cardiomyopathy, dilated, 1a | Enrichment | MYBPC3, TNNI3, TTN | 2.43 |
| 182 | Polymicrogyria | Enrichment | ATP1A2, SCN3A | 2.40 |
| 183 | Short stature with nonspecific skeletal abnormalities 1 | Enrichment | NPR2 | 2.38 |
| 184 | Malignant epithelioid hemangioendothelioma | Enrichment | WWTR1 | 2.38 |
| 185 | Transposition of the great arteries | Enrichment | GATA4 | 2.38 |
| 186 | Pseudomyogenic hemangioendothelioma | Enrichment | WWTR1 | 2.38 |
| 187 | Anhidrosis, isolated, with normal sweat glands | Enrichment | ITPR2 | 2.38 |
| 188 | Pyloric stenosis, infantile hypertrophic, 1 | Enrichment | NOS1 | 2.38 |
| 189 | Traboulsi syndrome | Enrichment | ASPH | 2.38 |
| 190 | Hyperinsulinemic hypoglycemia, familial, 2 | Enrichment | KCNJ11 | 2.38 |
| 191 | Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss | Enrichment | ATP1A3 | 2.38 |
| 192 | Cardiomyopathy, dilated, 2a | Enrichment | TNNI3 | 2.38 |
| 193 | Cardiomyopathy, familial hypertrophic, 7 | Enrichment | TNNI3 | 2.38 |
| 194 | Cardiac arrhythmia syndrome, with or without skeletal muscle weakness | Enrichment | TRDN | 2.38 |
| 195 | Alternating hemiplegia of childhood 2 | Enrichment | ATP1A3 | 2.38 |
| 196 | Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies | Enrichment | ATP1A2 | 2.38 |
| 197 | Intellectual disability and myopathy syndrome | Enrichment | ABCC9 | 2.38 |
| 198 | Intellectual developmental disorder, autosomal dominant 66 | Enrichment | ATP2B1 | 2.38 |
| 199 | Congenital myopathy 20 | Enrichment | RYR3 | 2.38 |
| 200 | Developmental and epileptic encephalopathy 99 | Enrichment | ATP1A3 | 2.38 |
| 201 | Deafness, autosomal dominant 82 | Enrichment | ATP2B2 | 2.38 |
| 202 | Charcot-marie-tooth disease, demyelinating, type 1j | Enrichment | ITPR3 | 2.38 |
| 203 | Intellectual developmental disorder, autosomal recessive 63 | Enrichment | CAMK2A | 2.38 |
| 204 | Intellectual developmental disorder, autosomal dominant 54 | Enrichment | CAMK2B | 2.38 |
| 205 | Diabetes mellitus, transient neonatal, 3 | Enrichment | KCNJ11 | 2.38 |
| 206 | Immunodeficiency 10 | Enrichment | STIM1 | 2.38 |
| 207 | Myopathy, vacuolar, with casq1 aggregates | Enrichment | CASQ1 | 2.38 |
| 208 | Long qt syndrome 16 | Enrichment | CALM3 | 2.38 |
| 209 | Diabetes mellitus, permanent neonatal, 2 | Enrichment | KCNJ11 | 2.38 |
| 210 | Pigmented nodular adrenocortical disease, primary, 4 | Enrichment | PRKACA | 2.38 |
| 211 | Maturity-onset diabetes of the young, type 13 | Enrichment | KCNJ11 | 2.38 |
| 212 | Cardioacrofacial dysplasia 1 | Enrichment | PRKACA | 2.38 |
| 213 | Developmental and epileptic encephalopathy 98 | Enrichment | ATP1A2 | 2.38 |
| 214 | Intellectual developmental disorder, autosomal dominant 53 | Enrichment | CAMK2A | 2.38 |
| 215 | Intellectual developmental disorder, autosomal dominant 59 | Enrichment | CAMK2G | 2.38 |
| 216 | Congenital myopathy with myasthenic-like onset | Enrichment | RYR1 | 2.38 |
| 217 | Long qt syndrome 15 | Enrichment | CALM2 | 2.38 |
| 218 | Myopathy due to calsequestrin and serca1 protein overload | Enrichment | CASQ1 | 2.38 |
| 219 | Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy | Enrichment | ITPR3 | 2.38 |
| 220 | Atp1a3-related disorder | Enrichment | ATP1A3 | 2.38 |
| 221 | Rhabdomyolysis 2 | Enrichment | ATP2A2 | 2.38 |
| 222 | Catecholaminergic polymorphic ventricular tachycardia 5 | Enrichment | TRDN | 2.38 |
| 223 | Oculogyric crisis | Enrichment | ATP1A3 | 2.38 |
| 224 | Hemiplegia | Enrichment | ATP1A3 | 2.38 |
| 225 | X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome | Enrichment | CLIC2 | 2.38 |
| 226 | Intermediate dend syndrome | Enrichment | KCNJ11 | 2.38 |
| 227 | Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency | Enrichment | KCNJ11 | 2.38 |
| 228 | Calf-predominant weakness-gastrocnemius medialis atrophy-distal myopathy | Enrichment | RYR1 | 2.38 |
| 229 | Benign samaritan congenital myopathy | Enrichment | RYR1 | 2.38 |
| 230 | Autosomal dominant hyperinsulinism due to kir6.2 deficiency | Enrichment | KCNJ11 | 2.38 |
| 231 | Autosomal recessive hyperinsulinism due to kir6.2 deficiency | Enrichment | KCNJ11 | 2.38 |
| 232 | Wolff syndrome | Enrichment | ATP7B | 2.38 |
| 233 | Neuronopathy, distal hereditary motor, x-linked | Enrichment | ATP7A | 2.38 |
| 234 | Hailey-hailey disease | Enrichment | ATP2C1 | 2.38 |
| 235 | Spastic paraplegia 78, autosomal recessive | Enrichment | ATP13A2 | 2.38 |
| 236 | Neurodevelopmental disorder with poor growth and behavioral abnormalities | Enrichment | ATP9A | 2.38 |
| 237 | Hemolytic anemia, congenital, x-linked | Enrichment | ATP11C | 2.38 |
| 238 | Deafness, autosomal dominant 33 | Enrichment | ATP11A | 2.38 |
| 239 | Occipital horn syndrome | Enrichment | ATP7A | 2.38 |
| 240 | Leukodystrophy, hypomyelinating, 24 | Enrichment | ATP11A | 2.38 |
| 241 | Kufor-rakeb syndrome | Enrichment | ATP13A2 | 2.38 |
| 242 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4 | Enrichment | ATP8A2 | 2.38 |
| 243 | Intellectual disability, wolff type | Enrichment | ATP7B | 2.38 |
| 244 | Auditory neuropathy, autosomal dominant 2 | Enrichment | ATP11A | 2.38 |
| 245 | Familial gastric type 1 neuroendocrine tumor | Enrichment | ATP4A | 2.38 |
| 246 | Parkinsonism due to atp13a2 deficiency | Enrichment | ATP13A2 | 2.38 |
| 247 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | ACTA2, ASPH, MYH11, MYLK | 2.37 |
| 248 | Cerebellar atrophy with seizures and variable developmental delay | Enrichment | CACNA2D2 | 2.35 |
| 249 | Third-degree atrioventricular block | Enrichment | KCNA5, TTN | 2.34 |
| 250 | Silver-russell syndrome 1 | Enrichment | KCNQ1 | 2.33 |
| 251 | Atrioventricular septal defect | Enrichment | TBX5 | 2.29 |
| 252 | Ventricular septal defect 1 | Enrichment | GATA4 | 2.29 |
| 253 | Congenital heart defects, multiple types, 4 | Enrichment | GATA4 | 2.29 |
| 254 | Pre-eclampsia | Enrichment | CORIN | 2.29 |
| 255 | Persistent truncus arteriosus | Enrichment | NKX2-5 | 2.29 |
| 256 | Epilepsy, idiopathic generalized | Enrichment | KCNIP1 | 2.25 |
| 257 | Multiple pterygium syndrome, lethal type | Enrichment | NEB, RYR1 | 2.22 |
| 258 | Congenital muscular dystrophy | Enrichment | RYR1, TTN | 2.22 |
| 259 | Hypoplastic left heart syndrome | Enrichment | MYH6, NKX2-5 | 2.22 |
| 260 | Conotruncal heart malformations | Enrichment | NKX2-5 | 2.21 |
| 261 | Double outlet right ventricle | Enrichment | NKX2-5 | 2.21 |
| 262 | Autosomal dominant non-syndromic intellectual disability | Enrichment | CACNA1I, CAMK2A, CAMK2B, SCN8A | 2.17 |
| 263 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | NKX2-5 | 2.14 |
| 264 | Arrhythmogenic right ventricular dysplasia, familial, 9 | Enrichment | PLN, TTN | 2.12 |
| 265 | Familial thoracic aortic aneurysm and dissection | Enrichment | MYH11, MYLK | 2.12 |
| 266 | Spinocerebellar ataxia 29 | Enrichment | ITPR1 | 2.08 |
| 267 | Seizures, benign familial neonatal, 1 | Enrichment | ATP1A3 | 2.08 |
| 268 | Hypomagnesemia 2, renal | Enrichment | FXYD2 | 2.08 |
| 269 | Malignant hyperthermia 1 | Enrichment | RYR1 | 2.08 |
| 270 | Cardiomyopathy, familial restrictive, 1 | Enrichment | TNNI3 | 2.08 |
| 271 | Acrokeratosis verruciformis | Enrichment | ATP2A2 | 2.08 |
| 272 | Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome | Enrichment | RYR2 | 2.08 |
| 273 | Spinocerebellar ataxia, x-linked 1 | Enrichment | ATP2B3 | 2.08 |
| 274 | Brody disease | Enrichment | ATP2A1 | 2.08 |
| 275 | Migraine, familial hemiplegic, 2 | Enrichment | ATP1A2 | 2.08 |
| 276 | Spinocerebellar ataxia, x-linked 5 | Enrichment | ATP2B3 | 2.08 |
| 277 | Cardiomyopathy, dilated, 1o | Enrichment | ABCC9 | 2.08 |
| 278 | Alternating hemiplegia of childhood 1 | Enrichment | ATP1A2 | 2.08 |
| 279 | Ventricular tachycardia, catecholaminergic polymorphic, 4 | Enrichment | CALM1 | 2.08 |
| 280 | Cardiomyopathy, dilated, 1p | Enrichment | PLN | 2.08 |
| 281 | Diabetes mellitus, permanent neonatal, 1 | Enrichment | KCNJ11 | 2.08 |
| 282 | Immunodeficiency 9 | Enrichment | ORAI1 | 2.08 |
| 283 | Atrial fibrillation, familial, 12 | Enrichment | ABCC9 | 2.08 |
| 284 | Cardiomyopathy, familial hypertrophic, 18 | Enrichment | PLN | 2.08 |
| 285 | Cardiomyopathy, dilated, 1ff | Enrichment | TNNI3 | 2.08 |
| 286 | Long qt syndrome 14 | Enrichment | CALM1 | 2.08 |
| 287 | Charcot-marie-tooth disease, axonal, type 2dd | Enrichment | ATP1A1 | 2.08 |
| 288 | Familial hemiplegic migraine | Enrichment | ATP1A2 | 2.08 |
| 289 | Myopathy, tubular aggregate, 2 | Enrichment | ORAI1 | 2.08 |
| 290 | King-denborough syndrome | Enrichment | RYR1 | 2.08 |
| 291 | Hypomagnesemia, seizures, and impaired intellectual development 2 | Enrichment | ATP1A1 | 2.08 |
| 292 | Fibrolamellar carcinoma | Enrichment | PRKACA | 2.08 |
| 293 | Dental caries | Enrichment | ATP2B3 | 2.08 |
| 294 | Hyperinsulinism | Enrichment | KCNJ11 | 2.08 |
| 295 | Developmental and epileptic encephalopathy 93 | Enrichment | ATP7B | 2.08 |
| 296 | Deafness, autosomal recessive 109 | Enrichment | ATP7B | 2.08 |
| 297 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome | Enrichment | ATP8A2 | 2.08 |
| 298 | Deafness, autosomal dominant 84 | Enrichment | ATP11A | 2.08 |
| 299 | West syndrome | Enrichment | SCN1A, SCN2A, SCN8A | 2.05 |
| 300 | Dystonia | Enrichment | ATP1A3, CAMK2B | 2.04 |
| 301 | Ventricular septal defect | Enrichment | TBX5 | 2.03 |
| 302 | Spinocerebellar ataxia 27a | Enrichment | FGF14 | 2.01 |
| 303 | Brugada syndrome 5 | Enrichment | SCN1B | 2.01 |
| 304 | Long qt syndrome 10 | Enrichment | SCN4B | 2.01 |
| 305 | Episodic pain syndrome, familial, 3 | Enrichment | SCN11A | 2.01 |
| 306 | Developmental and epileptic encephalopathy 11 | Enrichment | SCN2A | 2.01 |
| 307 | Neuropathy, hereditary sensory and autonomic, type vii | Enrichment | SCN11A | 2.01 |
| 308 | Atrial fibrillation, familial, 14 | Enrichment | SCN2B | 2.01 |
| 309 | Intellectual developmental disorder, x-linked 110 | Enrichment | FGF13 | 2.01 |
| 310 | Spinocerebellar ataxia 27b, late-onset | Enrichment | FGF14 | 2.01 |
| 311 | Myoclonus, familial, 2 | Enrichment | SCN8A | 2.01 |
| 312 | Developmental and epileptic encephalopathy 62 | Enrichment | SCN3A | 2.01 |
| 313 | Developmental and epileptic encephalopathy 90 | Enrichment | FGF13 | 2.01 |
| 314 | Atrial fibrillation, familial, 13 | Enrichment | SCN1B | 2.01 |
| 315 | Episodic ataxia, type 9 | Enrichment | SCN2A | 2.01 |
| 316 | Episodic pain syndrome, familial, 2 | Enrichment | SCN10A | 2.01 |
| 317 | Benign familial infantile epilepsy | Enrichment | SCN2A | 2.01 |
| 318 | Brugada syndrome 7 | Enrichment | SCN3B | 2.01 |
| 319 | Epilepsy, familial focal, with variable foci 4 | Enrichment | SCN3A | 2.01 |
| 320 | Developmental and epileptic encephalopathy 47 | Enrichment | FGF12 | 2.01 |
| 321 | Muscular channelopathy | Enrichment | SCN4A | 2.01 |
| 322 | Spinocerebellar ataxia type 27b | Enrichment | FGF14 | 2.01 |
| 323 | Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies | Enrichment | CACNA1C | 2.00 |
| 324 | Darier-white disease | Enrichment | ATP2A2 | 1.91 |
| 325 | Cantu syndrome | Enrichment | ABCC9 | 1.91 |
| 326 | Gillespie syndrome | Enrichment | ITPR1 | 1.91 |
| 327 | Lynch syndrome 5 | Enrichment | RYR1 | 1.91 |
| 328 | Bronchopulmonary dysplasia | Enrichment | RYR1 | 1.91 |
| 329 | Intellectual developmental disorder, autosomal dominant 30, with speech delay and behavioral abnormalities | Enrichment | ATP2B1 | 1.91 |
| 330 | Muscular atrophy | Enrichment | ATP2B3 | 1.91 |
| 331 | Dend syndrome | Enrichment | KCNJ11 | 1.91 |
| 332 | Cholestasis, intrahepatic, of pregnancy, 1 | Enrichment | ATP8B1 | 1.90 |
| 333 | Cholestasis, benign recurrent intrahepatic, 1 | Enrichment | ATP8B1 | 1.90 |
| 334 | Wilson disease | Enrichment | ATP7B | 1.90 |
| 335 | Menkes disease | Enrichment | ATP7A | 1.90 |
| 336 | Breast-ovarian cancer, familial 5 | Enrichment | ATP7B | 1.90 |
| 337 | Angelman syndrome due to imprinting defect in 15q11-q13 | Enrichment | ATP10A | 1.90 |
| 338 | Early infantile developmental and epileptic encephalopathy | Enrichment | SCN1B, SCN2A | 1.89 |
| 339 | Aortic valve disease 1 | Enrichment | NKX2-5 | 1.87 |
| 340 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | RYR2, TTN | 1.87 |
| 341 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | RYR2, TTN | 1.87 |
| 342 | 46,xy partial gonadal dysgenesis | Enrichment | GATA4 | 1.84 |
| 343 | Cardiomyopathy, familial hypertrophic, 2 | Enrichment | TNNT2 | 1.82 |
| 344 | Cardiomyopathy, familial hypertrophic, 3 | Enrichment | TPM1 | 1.82 |
| 345 | Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1a | Enrichment | MYH3 | 1.82 |
| 346 | Pulmonary atresia with intact ventricular septum | Enrichment | TPM1 | 1.82 |
| 347 | Myopathy, distal, with anterior tibial onset | Enrichment | DYSF | 1.82 |
| 348 | Muscular dystrophy, becker type | Enrichment | DMD | 1.82 |
| 349 | Cardiomyopathy, familial hypertrophic, 8 | Enrichment | MYL3 | 1.82 |
| 350 | Cardiomyopathy, dilated, 1aa, with or without left ventricular noncompaction | Enrichment | ACTN2 | 1.82 |
| 351 | Cardiomyopathy, familial restrictive, 3 | Enrichment | TNNT2 | 1.82 |
| 352 | Congenital myopathy 23 | Enrichment | TPM2 | 1.82 |
| 353 | Congenital myopathy 2a, typical, autosomal dominant | Enrichment | ACTA1 | 1.82 |
| 354 | Left ventricular noncompaction 10 | Enrichment | MYBPC3 | 1.82 |
| 355 | Congenital myopathy 4b, autosomal recessive | Enrichment | TPM3 | 1.82 |
| 356 | Nemaline myopathy 5a, autosomal recessive, severe infantile | Enrichment | TNNT1 | 1.82 |
| 357 | Lethal congenital contracture syndrome 4 | Enrichment | MYBPC1 | 1.82 |
| 358 | Myopathy, scapulohumeroperoneal | Enrichment | ACTA1 | 1.82 |
| 359 | Cardiomyopathy, dilated, 1ee | Enrichment | MYH6 | 1.82 |
| 360 | Sick sinus syndrome 3 | Enrichment | MYH6 | 1.82 |
| 361 | Scapuloperoneal syndrome, neurogenic, kaeser type | Enrichment | DES | 1.82 |
| 362 | Congenital myopathy 16 | Enrichment | MYBPC1 | 1.82 |
| 363 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 | Enrichment | ACTG2 | 1.82 |
| 364 | Muscular dystrophy, limb-girdle, autosomal recessive 7 | Enrichment | TCAP | 1.82 |
| 365 | Bleeding disorder, platelet-type, 25 | Enrichment | TPM4 | 1.82 |
| 366 | Neurodevelopmental disorder with speech impairment and with or without seizures | Enrichment | CACNA1I | 1.82 |
| 367 | Knobloch syndrome 2 | Enrichment | PAK2 | 1.82 |
| 368 | Congenital myopathy 8 | Enrichment | ACTN2 | 1.82 |
| 369 | Intellectual developmental disorder with macrocephaly, seizures, and speech delay | Enrichment | PAK1 | 1.82 |
| 370 | Cardiomyopathy, dilated, 3b | Enrichment | DMD | 1.82 |
| 371 | Atrial fibrillation, familial, 18 | Enrichment | MYL4 | 1.82 |
| 372 | Alcohol sensitivity, acute | Enrichment | ALDH2 | 1.82 |
| 373 | Cardiomyopathy, dilated, 1w | Enrichment | VCL | 1.82 |
| 374 | Epilepsy, childhood absence 6 | Enrichment | CACNA1H | 1.82 |
| 375 | Actn3 deficiency | Enrichment | ACTN3 | 1.82 |
| 376 | Visceral neuropathy, familial, 3, autosomal dominant | Enrichment | ACTG2 | 1.82 |
| 377 | Cardiomyopathy, familial hypertrophic, 14 | Enrichment | MYH6 | 1.82 |
| 378 | Autosomal recessive limb-girdle muscular dystrophy type 2g | Enrichment | TCAP | 1.82 |
| 379 | Cardiomyopathy, familial hypertrophic, 15 | Enrichment | VCL | 1.82 |
| 380 | Congenital myopathy 2b, severe infantile, autosomal recessive | Enrichment | ACTA1 | 1.82 |
| 381 | Moyamoya disease 6 with or without achalasia | Enrichment | GUCY1A1 | 1.82 |
| 382 | Autosomal dominant familial visceral neuropathy | Enrichment | ACTG2 | 1.82 |
| 383 | Spinocerebellar ataxia 42 | Enrichment | CACNA1G | 1.82 |
| 384 | Cardiomyopathy, dilated, 1z | Enrichment | TNNC1 | 1.82 |
| 385 | Cardiomyopathy, familial hypertrophic, 13 | Enrichment | TNNC1 | 1.82 |
| 386 | Arthrogryposis, distal, type 1b | Enrichment | MYBPC1 | 1.82 |
| 387 | Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits | Enrichment | CACNA1G | 1.82 |
| 388 | Hyperaldosteronism, familial, type iv | Enrichment | CACNA1H | 1.82 |
| 389 | Congenital myopathy 15 | Enrichment | TNNC2 | 1.82 |
| 390 | Congenital myopathy 2c, severe infantile, autosomal dominant | Enrichment | ACTA1 | 1.82 |
| 391 | Myopathy, distal, 6, adult-onset, autosomal dominant | Enrichment | ACTN2 | 1.82 |
| 392 | Congenital myopathy 14 | Enrichment | MYL1 | 1.82 |
| 393 | Nemaline myopathy 5b, autosomal recessive, childhood-onset | Enrichment | TNNT1 | 1.82 |
| 394 | Moyamoya disease with early-onset achalasia | Enrichment | GUCY1A1 | 1.82 |
| 395 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 3 | Enrichment | LMOD1 | 1.82 |
| 396 | Arthrogryposis, distal, type 2b2 | Enrichment | TNNT3 | 1.82 |
| 397 | Nemaline myopathy 5a | Enrichment | TNNT1 | 1.82 |
| 398 | Mybpc1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome | Enrichment | MYBPC1 | 1.82 |
| 399 | Symptomatic form of muscular dystrophy of duchenne and becker in female carriers | Enrichment | DMD | 1.82 |
| 400 | Conn's syndrome | Enrichment | CACNA1H | 1.82 |
| 401 | Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome | Enrichment | TTN | 1.82 |
| 402 | Zebra body myopathy | Enrichment | ACTA1 | 1.82 |
| 403 | Capillary leak syndrome | Enrichment | TLN1 | 1.82 |
| 404 | Duchenne and becker muscular dystrophy | Enrichment | DMD | 1.82 |
| 405 | Actin-accumulation myopathy | Enrichment | ACTA1 | 1.82 |
| 406 | Premature aging | Enrichment | VIM | 1.82 |
| 407 | Myopathic intestinal pseudoobstruction | Enrichment | ACTG2 | 1.82 |
| 408 | Congenital generalized hypercontractile muscle stiffness syndrome | Enrichment | TPM3 | 1.82 |
| 409 | Distal nebulin myopathy | Enrichment | NEB | 1.82 |
| 410 | Qualitative or quantitative defects of dystrophin | Enrichment | DMD | 1.82 |
| 411 | Actg2 visceral myopathy | Enrichment | ACTG2 | 1.82 |
| 412 | Congenital myopathy, paradas type | Enrichment | DYSF | 1.82 |
| 413 | Ear malformation | Enrichment | KCNQ1 | 1.80 |
| 414 | Hypertension | Enrichment | CORIN | 1.79 |
| 415 | Congenital myopathy 1a, autosomal dominant, with malignant hyperthermia | Enrichment | RYR1 | 1.78 |
| 416 | Myotonic dystrophy 1 | Enrichment | DMPK | 1.78 |
| 417 | Sacral defect with anterior meningocele | Enrichment | RYR1 | 1.78 |
| 418 | Dermatitis, atopic | Enrichment | KCNJ11 | 1.78 |
| 419 | Amyotrophy, monomelic | Enrichment | RYR3 | 1.78 |
| 420 | Myopathy, autophagic vacuolar, infantile-onset | Enrichment | STIM1 | 1.78 |
| 421 | Spinocerebellar ataxia 15 | Enrichment | ITPR1 | 1.78 |
| 422 | Intellectual developmental disorder, autosomal dominant 26 | Enrichment | RYR1 | 1.78 |
| 423 | Neonatal diabetes mellitus | Enrichment | KCNJ11 | 1.78 |
| 424 | Congenital myopathy 1a | Enrichment | RYR1 | 1.78 |
| 425 | Idiopathic achalasia | Enrichment | NOS1 | 1.78 |
| 426 | Intrahepatic cholestasis of pregnancy | Enrichment | ATP8B1 | 1.78 |
| 427 | Atrial standstill 1 | Enrichment | SCN5A | 1.71 |
| 428 | Progressive familial heart block, type ia | Enrichment | SCN5A | 1.71 |
| 429 | Paramyotonia congenita | Enrichment | SCN4A | 1.71 |
| 430 | Batten-turner congenital myopathy | Enrichment | SCN4A | 1.71 |
| 431 | Indifference to pain, congenital, autosomal recessive | Enrichment | SCN9A | 1.71 |
| 432 | Seizures, benign familial infantile, 3 | Enrichment | SCN2A | 1.71 |
| 433 | Sick sinus syndrome 1 | Enrichment | SCN5A | 1.71 |
| 434 | Myotonia, potassium-aggravated | Enrichment | SCN4A | 1.71 |
| 435 | Atrial fibrillation, familial, 10 | Enrichment | SCN5A | 1.71 |
| 436 | Migraine, familial hemiplegic, 3 | Enrichment | SCN1A | 1.71 |
| 437 | Cognitive impairment with or without cerebellar ataxia | Enrichment | SCN8A | 1.71 |
| 438 | Long qt syndrome 3 | Enrichment | SCN5A | 1.71 |
| 439 | Developmental and epileptic encephalopathy 6b | Enrichment | SCN1A | 1.71 |
| 440 | Sinoatrial node disease | Enrichment | SCN5A | 1.71 |
| 441 | Congenital myopathy 22a, classic | Enrichment | SCN4A | 1.71 |
| 442 | Congenital myopathy 22b, severe fetal | Enrichment | SCN4A | 1.71 |
| 443 | Myasthenic syndrome, congenital, 16 | Enrichment | SCN4A | 1.71 |
| 444 | Benign familial neonatal epilepsy | Enrichment | SCN2A | 1.71 |
| 445 | Developmental and epileptic encephalopathy 30 | Enrichment | SCN2A | 1.71 |
| 446 | Hypokalemic periodic paralysis, type 2 | Enrichment | SCN4A | 1.71 |
| 447 | Scn1a seizure disorders | Enrichment | SCN1A | 1.71 |
| 448 | Seizures, benign familial infantile, 5 | Enrichment | SCN8A | 1.71 |
| 449 | Malignant migrating partial seizures of infancy | Enrichment | SCN2A | 1.71 |
| 450 | Developmental and epileptic encephalopathy 76 | Enrichment | SCN1A | 1.71 |
| 451 | Small fiber neuropathy | Enrichment | SCN9A | 1.71 |
| 452 | Benign neonatal seizures | Enrichment | SCN2A | 1.71 |
| 453 | Neuropathy, hereditary motor and sensory, okinawa type | Enrichment | MME | 1.71 |
| 454 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | ATP11A, ATP2B2 | 1.70 |
| 455 | Craniosynostosis | Enrichment | NPR2 | 1.69 |
| 456 | Transient neonatal diabetes mellitus | Enrichment | KCNJ11 | 1.69 |
| 457 | Hypoglycemia | Enrichment | KCNJ11 | 1.69 |
| 458 | Developmental and epileptic encephalopathy 1 | Enrichment | SCN1A, SCN8A | 1.61 |
| 459 | Myopathy, centronuclear, 1 | Enrichment | RYR1 | 1.61 |
| 460 | Hyperinsulinemic hypoglycemia, familial, 1 | Enrichment | KCNJ11 | 1.61 |
| 461 | Pierre robin syndrome | Enrichment | ATP2B1 | 1.61 |
| 462 | Deafness, autosomal recessive 12 | Enrichment | ATP2B2 | 1.61 |
| 463 | Kleefstra syndrome 1 | Enrichment | ABCC9 | 1.61 |
| 464 | Spinocerebellar ataxia, autosomal recessive 16 | Enrichment | ITPR1 | 1.61 |
| 465 | Patent ductus arteriosus | Enrichment | ABCC9 | 1.61 |
| 466 | Hypertrichosis | Enrichment | KCNJ11 | 1.61 |
| 467 | Nonsyndromic genetic hyperinsulinism | Enrichment | KCNJ11 | 1.61 |
| 468 | Cholestasis, progressive familial intrahepatic, 1 | Enrichment | ATP8B1 | 1.60 |
| 469 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 1 | Enrichment | ATP8A2 | 1.60 |
| 470 | Bethlem myopathy 1a | Enrichment | DMPK | 1.54 |
| 471 | Megacolon | Enrichment | SLC8A1 | 1.54 |
| 472 | Generalized epilepsy with febrile seizures plus, type 2 | Enrichment | SCN1A | 1.54 |
| 473 | Developmental and epileptic encephalopathy 13 | Enrichment | SCN8A | 1.54 |
| 474 | Generalized epilepsy with febrile seizures plus, type 7 | Enrichment | SCN9A | 1.54 |
| 475 | Tremor, hereditary essential, 6 | Enrichment | SCN4A | 1.54 |
| 476 | Hereditary episodic ataxia | Enrichment | SCN2A | 1.54 |
| 477 | Progressive familial intrahepatic cholestasis | Enrichment | ATP8B1 | 1.54 |
| 478 | Aortic aneurysm, familial thoracic 4 | Enrichment | MYH11 | 1.52 |
| 479 | Arthrogryposis, distal, type 2a | Enrichment | MYH3 | 1.52 |
| 480 | Miyoshi muscular dystrophy 1 | Enrichment | DYSF | 1.52 |
| 481 | Lethal congenital contracture syndrome 3 | Enrichment | MYBPC1 | 1.52 |
| 482 | Aortic aneurysm, familial thoracic 2 | Enrichment | ACTA2 | 1.52 |
| 483 | Cardiomyopathy, dilated, 1r | Enrichment | ACTC1 | 1.52 |
| 484 | Arthrogryposis, distal, type 7 | Enrichment | MYH8 | 1.52 |
| 485 | Cardiomyopathy, familial hypertrophic, 11 | Enrichment | ACTC1 | 1.52 |
| 486 | Smooth muscle dysfunction syndrome | Enrichment | ACTA2 | 1.52 |
| 487 | Aortic aneurysm, familial thoracic 6 | Enrichment | ACTA2 | 1.52 |
| 488 | Moyamoya disease 5 | Enrichment | ACTA2 | 1.52 |
| 489 | Cardiomyopathy, dilated, 1dd | Enrichment | TNNT2 | 1.52 |
| 490 | Atrial septal defect 5 | Enrichment | ACTC1 | 1.52 |
| 491 | Amed syndrome, digenic | Enrichment | ALDH2 | 1.52 |
| 492 | Arthrogryposis, distal, type 2b3 | Enrichment | MYH3 | 1.52 |
| 493 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 | Enrichment | MYH11 | 1.52 |
| 494 | Cardiomyopathy, dilated, 1d | Enrichment | TNNT2 | 1.52 |
| 495 | Nemaline myopathy 5c, autosomal dominant | Enrichment | TNNT1 | 1.52 |
| 496 | Atrial septal defect 3 | Enrichment | MYH6 | 1.52 |
| 497 | Progressive familial heart block | Enrichment | DES | 1.52 |
| 498 | Cataract 30 | Enrichment | VIM | 1.52 |
| 499 | Cardiomyopathy, familial hypertrophic, 10 | Enrichment | MYL2 | 1.52 |
| 500 | Visceral myopathy 2 | Enrichment | MYH11 | 1.52 |
| 501 | Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy | Enrichment | MYL2 | 1.52 |
| 502 | Arthrogryposis, distal, type 1c | Enrichment | MYL11 | 1.52 |
| 503 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 | Enrichment | MYL9 | 1.52 |
| 504 | Inclusion myopathy | Enrichment | TTN | 1.52 |
| 505 | Qualitative or quantitative defects of caveolin-3 | Enrichment | CAV3 | 1.52 |
| 506 | Intestinal obstruction | Enrichment | ACTG2 | 1.52 |
| 507 | Carney complex - trismus - pseudocamptodactyly syndrome | Enrichment | MYH8 | 1.52 |
| 508 | Sensorineural hearing loss | Enrichment | KCNE1 | 1.50 |
| 509 | Peripheral nervous system disease | Enrichment | MME | 1.49 |
| 510 | Neuropathy | Enrichment | MME | 1.49 |
| 511 | Fanconi anemia, complementation group c | Enrichment | ABCC9 | 1.49 |
| 512 | Permanent neonatal diabetes mellitus | Enrichment | KCNJ11 | 1.49 |
| 513 | Body mass index quantitative trait locus 11 | Enrichment | KCNH2 | 1.49 |
| 514 | Complex neurodevelopmental disorder | Enrichment | ATP2B1, CACNA1C, SCN2A, SCN8A | 1.48 |
| 515 | Ellis-van creveld syndrome | Enrichment | PRKACA | 1.44 |
| 516 | Neuropathy, hereditary sensory and autonomic, type iia | Enrichment | SCN9A | 1.42 |
| 517 | Hyperkalemic periodic paralysis | Enrichment | SCN4A | 1.42 |
| 518 | Developmental and epileptic encephalopathy 12 | Enrichment | SCN2A | 1.42 |
| 519 | Hereditary sensory and autonomic neuropathy type 2 | Enrichment | SCN9A | 1.42 |
| 520 | Developmental and epileptic encephalopathy 52 | Enrichment | SCN1B | 1.42 |
| 521 | Sotos syndrome 1 | Enrichment | SCN4A | 1.42 |
| 522 | Episodic ataxia | Enrichment | SCN2A | 1.42 |
| 523 | Sick sinus syndrome | Enrichment | SCN5A | 1.42 |
| 524 | Neurodegeneration with brain iron accumulation | Enrichment | ATP13A2 | 1.38 |
| 525 | Cerebral palsy | Enrichment | CACNA1C | 1.37 |
| 526 | Diabetes mellitus | Enrichment | KCNJ11 | 1.35 |
| 527 | Muscular dystrophy, duchenne type | Enrichment | DMD | 1.35 |
| 528 | Rippling muscle disease 2 | Enrichment | CAV3 | 1.35 |
| 529 | Spondylocarpotarsal synostosis syndrome | Enrichment | MYH3 | 1.35 |
| 530 | Long qt syndrome 9 | Enrichment | CAV3 | 1.35 |
| 531 | Nonaka myopathy | Enrichment | TTN | 1.35 |
| 532 | Aortic aneurysm, familial thoracic 7 | Enrichment | MYLK | 1.35 |
| 533 | Myopathy, distal, tateyama type | Enrichment | CAV3 | 1.35 |
| 534 | Arthrogryposis multiplex congenita 6 | Enrichment | NEB | 1.35 |
| 535 | Tricuspid valve insufficiency | Enrichment | MYH11 | 1.35 |
| 536 | Dysferlinopathy | Enrichment | DYSF | 1.35 |
| 537 | Sotos syndrome | Enrichment | SCN4A | 1.32 |
| 538 | Convulsions, familial infantile, with paroxysmal choreoathetosis | Enrichment | SCN8A | 1.32 |
| 539 | Sensory peripheral neuropathy | Enrichment | SCN11A | 1.32 |
| 540 | Multiple sclerosis | Enrichment | ITPR1 | 1.25 |
| 541 | Periventricular nodular heterotopia | Enrichment | ATP2B1 | 1.25 |
| 542 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | GATA4 | 1.25 |
| 543 | Pain disorder | Enrichment | SCN4A | 1.24 |
| 544 | Autoimmune lymphoproliferative syndrome | Enrichment | ACTA2 | 1.23 |
| 545 | Carney complex variant | Enrichment | MYH8 | 1.23 |
| 546 | Left ventricular noncompaction 2 | Enrichment | TTN | 1.23 |
| 547 | Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1b | Enrichment | MYH3 | 1.23 |
| 548 | Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | Enrichment | MYH11 | 1.23 |
| 549 | Knobloch syndrome | Enrichment | PAK2 | 1.23 |
| 550 | Anterior segment dysgenesis | Enrichment | ITPR1 | 1.22 |
| 551 | Hydrocephalus, congenital, 1 | Enrichment | ATP1A3 | 1.19 |
| 552 | Polymicrogyria, bilateral perisylvian, x-linked | Enrichment | SCN3A | 1.18 |
| 553 | Hypertension, essential | Enrichment | ATP1B1 | 1.17 |
| 554 | Interstitial lung disease 2 | Enrichment | ATP11A | 1.16 |
| 555 | Feingold syndrome 1 | Enrichment | TTN | 1.13 |
| 556 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | TTN | 1.13 |
| 557 | Knobloch syndrome 1 | Enrichment | PAK2 | 1.13 |
| 558 | Autosomal recessive limb-girdle muscular dystrophy type 2b | Enrichment | DYSF | 1.13 |
| 559 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | TTN | 1.13 |
| 560 | Histiocytoid hemangioma | Enrichment | VIM | 1.13 |
| 561 | Lennox-gastaut syndrome | Enrichment | SCN1A | 1.12 |
| 562 | Maturity-onset diabetes of the young | Enrichment | KCNJ11 | 1.10 |
| 563 | Myoclonic-atonic epilepsy | Enrichment | SCN1A | 1.07 |
| 564 | Bilateral perisylvian polymicrogyria | Enrichment | SCN3A | 1.07 |
| 565 | Familial isolated arrhythmogenic right ventricular dysplasia | Enrichment | SCN5A | 1.07 |
| 566 | Alcohol dependence | Enrichment | ALDH2 | 1.06 |
| 567 | Childhood absence epilepsy | Enrichment | CACNA1H | 1.06 |
| 568 | Microcephaly | Enrichment | ATP2B3, CAMK2B | 1.04 |
| 569 | Scoliosis | Enrichment | RYR1 | 1.02 |
| 570 | Myofibrillar myopathy | Enrichment | DES | 1.00 |
| 571 | Movement disease | Enrichment | SCN2A | 0.99 |
| 572 | Postsynaptic congenital myasthenic syndromes | Enrichment | SCN4A | 0.96 |
| 573 | Orthostatic intolerance | Enrichment | TTN | 0.94 |
| 574 | Hirschsprung disease 1 | Enrichment | ATP7A | 0.94 |
| 575 | Orofacial cleft 1 | Enrichment | TTN | 0.89 |
| 576 | Primary hyperaldosteronism | Enrichment | CACNA1H | 0.89 |
| 577 | Limb-girdle muscular dystrophy | Enrichment | TTN | 0.89 |
| 578 | Cataract 30, multiple types | Enrichment | VIM | 0.85 |
| 579 | Tibial muscular dystrophy, tardive | Enrichment | TTN | 0.85 |
| 580 | Myopathy, myofibrillar, 9, with early respiratory failure | Enrichment | TTN | 0.85 |
| 581 | Tibial muscular dystrophy | Enrichment | TTN | 0.85 |
| 582 | Autosomal dominant macrothrombocytopenia | Enrichment | TPM4 | 0.85 |
| 583 | Pectus excavatum | Enrichment | DMD | 0.81 |
| 584 | Cardiomyopathy, familial hypertrophic, 9 | Enrichment | TTN | 0.81 |
| 585 | Type 2 diabetes mellitus | Enrichment | KCNJ11 | 0.80 |
| 586 | Muscular dystrophy, limb-girdle, autosomal recessive 2 | Enrichment | DYSF | 0.78 |
| 587 | Congenital myopathy 5 with cardiomyopathy | Enrichment | TTN | 0.75 |
| 588 | Lung cancer susceptibility 3 | Enrichment | ACTA2 | 0.72 |
| 589 | Malaria | Enrichment | SCN8A | 0.70 |
| 590 | Myopia | Enrichment | MYH11 | 0.69 |
| 591 | Primary ovarian insufficiency | Enrichment | RYR3 | 0.66 |
| 592 | Muscular dystrophy, limb-girdle, autosomal recessive 10 | Enrichment | TTN | 0.60 |
| 593 | Autosomal recessive limb-girdle muscular dystrophy | Enrichment | DYSF | 0.60 |
| 594 | Autosomal recessive limb-girdle muscular dystrophy type 2j | Enrichment | TTN | 0.56 |
| 595 | Cardiomyopathy, dilated, 1g | Enrichment | TTN | 0.55 |
| 596 | Myocardial infarction | Enrichment | GUCY1A1 | 0.55 |
| 597 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | ATP2B2 | 0.51 |
| 598 | Hydrops fetalis, nonimmune | Enrichment | ACTA1 | 0.49 |
| 599 | Congenital nervous system abnormality | Enrichment | CAMK2B | 0.45 |
| 600 | Nervous system disease | Enrichment | CAMK2B | 0.45 |
| 601 | Non-immune hydrops fetalis | Enrichment | ACTA1 | 0.42 |
| 602 | Lung cancer | Enrichment | ACTA2 | 0.41 |
| 603 | Connective tissue disease | Enrichment | ACTA2 | 0.41 |
| 604 | Fanconi anemia, complementation group a | Enrichment | DMD | 0.38 |
| 605 | Non-syndromic x-linked intellectual disability | Enrichment | DMD | 0.37 |
| 606 | Schizophrenia | Enrichment | DMD | 0.23 |
| 607 | Autism spectrum disorder | Enrichment | SCN2A | 0.18 |
| 608 | Colorectal cancer | Enrichment | DMD | 0.13 |